Becton Dickinson (NY: BDX )
235.89 USD UNCHANGED Streaming Delayed Price Updated: 7:29 PM EDT, Oct 28, 2020 Add to My Watchlist
Press releases about Becton Dickinson
BD Announces Executive Leadership Appointments
October 22, 2020
CerTest Biotec and BD Announce CE Mark for Combination COVID-19, Influenza, RSV Test on BD MAX™ Molecular Diagnostic System
October 21, 2020
CerTest Biotec, along with BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that the VIASURE SARS-CoV-2 (N1 + N2) Real Time PCR Detection Kit...
High Content Screening Market 2020: Analysis, Top Companies, Size, Share, Demand and Opportunity To 2025
October 14, 2020
From AB Newswire
BioGX Announces FDA Emergency Use Authorization Submission Of Extraction-Free Direct RT-PCR Test for COVID-19
October 13, 2020
From Get News
BD marks 25 years with Mercy Ships: Donates $1M to support launch of world's largest NGO hospital ship
October 07, 2020
Global Mercy will deliver free, world-class surgical care to patients in African nations who lack healthcare access
BD Granted FDA 510(k) Clearance for BD FACSLyric™ Flow Cytometer with Newly Integrated BD FACSDuet™ Sample Preparation System
October 05, 2020
BD FACSDuet™ Sample Preparation System, now available in the U.S., as the first fully automated sample-to-answer solution when integrated with the BD FACSLyric™ Flow Cytometer
BD (Becton, Dickinson and Company) (NYSE:BDX) announced today that it will conduct a live webcast of its fourth fiscal quarter and full fiscal year 2020 earnings conference call on Thursday, November...
BD Announces CE Mark of Portable, Rapid Point-of-Care Antigen Test to Detect SARS-CoV-2 in 15 minutes
September 30, 2020
BD Submits Pre-Market Approval Supplement to FDA to Enable ThinPrep® Pap Test™ PreservCyt® Solution to be Used with the BD Onclarity™ HPV Assay
September 23, 2020
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it has submitted a pre-market approval (PMA) supplement to the U.S. Food and Drug...
BD Announces FDA Classifications for August 4th Recalls of BD Alaris™ System Hardware for Keypads, Incorrect Module Types and/or Sizes, and Channel Error
September 21, 2020
New Head-to-Head Study Demonstrates Equivalency and Accuracy of COVID-19 Rapid Point-of-Care Tests, Despite Different Test Sensitivity Claims
September 09, 2020
Results show clinical study design may influence performance estimates and published sensitivity claims of SARS-CoV-2 antigen tests
BD to Present at Investor Healthcare Conferences
August 31, 2020
BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, announced today that it will present at the following upcoming virtual investor healthcare conferences:
ReverseVision Taps Credit Union Veteran Justin Burns as VP Operations, Invests in Platform Enhancements with Hire of Two Senior Software Engineers
August 26, 2020
From Send2Press Newswire
Kristen Stewart to Join BD as Senior Vice President of Strategy and Investor Relations
August 17, 2020
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today the appointment of Kristen Stewart to the newly created position of senior vice president of...
BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, announced today that it will present at the UBS Genomics 2.0 and MedTech Innovations Virtual Summit on...
BD and BD Foundation commit $7.8 million to helping community health centers expand innovative care to patients
August 10, 2020
BD (NYSE: BDX), a leading global medical technology company, together with the BD Foundation, its charitable affiliate, today committed $7.8 million in monetary grants and product donations over the...
STERIS Announces Financial Results for Fiscal 2021 First Quarter
August 03, 2020
BD releases FY 2019 Sustainability Report
August 03, 2020
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today issued its 2019 Sustainability Report, focusing on performance of the environmental, social and...
BD Announces $24 Million U.S. Government Investment to Support Scale Up of U.S. Manufacturing of COVID-19 Diagnosic Tests
July 30, 2020
Capital investments will enable U.S. manufacturing of 8 million BD Veritor™ brand SARS-CoV-2 tests per month
BD Board Declares Dividends
July 27, 2020
The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX) has declared a quarterly dividend of $0.79 per common share, payable on September 30, 2020 to holders of record on September 9,...
BD Onclarity™ HPV Assay is the only FDA-approved HPV assay to individually identify and report genotypes beyond 16, 18 and 45
BD Receives Additional Orders For 177 Million Injection Devices For U.S., Canada COVID-19 Vaccine Preparations
July 21, 2020
BD Supports U.S. Government Efforts to Increase COVID-19 Testing Capacity with Point-of-Care Tests
July 15, 2020
BD Partners with U.S. Government on $70 Million Manufacturing Infrastructure Project for Mass Vaccination Campaigns
July 08, 2020
Company Finalizes Initial Pandemic Order for 50 Million Injection Devices to Support Operation Warp Speed Vaccination Program
BD Launches First and Only Fully Sterile Povidone-Iodine and Isopropyl Alcohol Skin Preparation
July 07, 2020
New BD PurPrep™ skin preparation is the only commercially available PVP-I antiseptic skin preparation with sterile solution in the U.S.
BD Launches Portable, Rapid Point-of-Care Antigen Test to Detect SARS-CoV-2 in 15 minutes, Dramatically Expanding Access to COVID-19 Testing
July 06, 2020
- Simple new assay leverages more than 25,000 BD Veritor™ instruments already used across the U.S. to immediately increase access to COVID-19 testing in frontline health care settings
BD (Becton, Dickinson and Company) (NYSE:BDX) announced today that it will conduct a live webcast of its third fiscal quarter 2020 earnings conference call on Thursday, August 6, 2020, at 8:00 a.m....